PSORIATIC ARTHRITIS, JUVENILE

Clinical trials for PSORIATIC ARTHRITIS, JUVENILE explained in plain language.

Never miss a new study

Get alerted when new PSORIATIC ARTHRITIS, JUVENILE trials appear

Sign up with your email to follow new studies for PSORIATIC ARTHRITIS, JUVENILE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Drug maker tracks Kids' arthritis treatment experience

Disease control Recruiting now

This study is monitoring children aged 2-18 who are already taking Xeljanz for juvenile arthritis in routine Korean medical practice. Researchers will track their treatment experience for up to 44 weeks to understand the drug's safety and effectiveness in real-world use. This is …

Matched conditions: PSORIATIC ARTHRITIS, JUVENILE

Sponsor: Pfizer • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

PSORIATIC ARTHRITIS, JUVENILE

Get alerted when new PSORIATIC ARTHRITIS, JUVENILE trials appear

Drug maker tracks Kids' arthritis treatment experience